Literature DB >> 29866283

Updates in the Evaluation and Management of Breast Cancer.

Ciara C O'Sullivan1, Charles L Loprinzi1, Tufia C Haddad2.   

Abstract

Breast cancer is the most commonly diagnosed cancer worldwide. More than 200,000 new cases of invasive breast cancer are diagnosed annually in the United States; approximately 40,000 patients die of the disease. The etiology of most breast cancer cases is unknown, although multiple factors predisposing to the disease have been identified. Apart from increasing age and female sex, these other factors account for only a minority of breast cancer diagnoses. This article provides an overview of the management of noninvasive and invasive breast cancer, which is often complex and varies according to patient factors, disease stage, and breast cancer subtype. Although much progress has been made, continued research endeavors are ongoing; enrollment of eligible patients in prospective clinical trials is an essential way to improve patient outcomes.
Copyright © 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29866283     DOI: 10.1016/j.mayocp.2018.03.025

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  14 in total

1.  Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.

Authors:  Pengfei Zheng; Liangpeng Dong; Bin Zhang; Jinfang Dai; Yifu Zhang; Yanan Wang; Shuang Qin
Journal:  Histochem Cell Biol       Date:  2019-07-27       Impact factor: 4.304

2.  Long Non-coding RNA LINC01224 Promotes the Malignant Behaviors of Triple Negative Breast Cancer Cells via Regulating the miR-193a-5p/NUP210 Axis.

Authors:  Kai Sang; Tongbo Yi; Chi Pan; Jian Zhou; Lei Yu
Journal:  Mol Biotechnol       Date:  2022-09-20       Impact factor: 2.860

Review 3.  PIK3CA gene aberrancy and role in targeted therapy of solid malignancies.

Authors:  Owen Willis; Khalil Choucair; Abdurahman Alloghbi; Laura Stanbery; Rex Mowat; F Charles Brunicardi; Lance Dworkin; John Nemunaitis
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

4.  The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis.

Authors:  Li Xie; Gang Feng; Ping Zhu; Jiang Xie
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

5.  Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3.

Authors:  Xuan Fang; Jin Zhang; Chunyan Li; Jinjin Liu; Zhendong Shi; Peng Zhou
Journal:  Cancer Cell Int       Date:  2020-06-17       Impact factor: 5.722

6.  Derivative of Stevioside; CPUK02; Restores ESR1 Gene Methylation in MDA-MB 231

Authors:  Saeed Khazayel; Pooneh Mokarram; Zeinab Mohammadi; Fatemeh Ramezani; Zhang Dayong
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

7.  LncRNA MIR503HG inhibits cell migration and invasion via miR-103/OLFM4 axis in triple negative breast cancer.

Authors:  Jia Fu; Guanjun Dong; Hui Shi; Junfeng Zhang; Zhaochen Ning; Xingna Bao; Chenjie Liu; Jing Hu; Minghui Liu; Bin Xiong
Journal:  J Cell Mol Med       Date:  2019-05-06       Impact factor: 5.310

8.  Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer.

Authors:  Thomas Decker; Ulrike Söling; Antje Hahn; Christoph Maintz; Christian Martin Kurbacher; Ursula Vehling-Kaiser; Dagmar Sent; Peter Klare; Volker Hagen; Marco Chiabudini; Julia Falkenstein; Martin Indorf; Eva Runkel; Karin Potthoff
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

9.  The study of sirtuins in breast cancer patients before and after radiotherapy

Authors:  Nazlı Helvacı; Hatice Saraçoğlu; Oğuz Galip Yıldız; Eser Kılıç
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

10.  Genetic Variation and Hot Flashes: A Systematic Review.

Authors:  Carolyn J Crandall; Allison L Diamant; Margaret Maglione; Rebecca C Thurston; Janet Sinsheimer
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.